跳至主要内容
临床试验/CTRI/2024/03/063428
CTRI/2024/03/063428尚未招募Unknown

Identifying responder/non-responder status prior to anti-PD L1 or neo adjuvant/ palliative chemotherapy in Lung and Head and Neck cancers using a novel bioinformatic approach to analyze biomarker data. - NI

Tata Memorial Centre0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1.Lung (NSCLC) and oral (OSCC) cancer patients (Histo-pathologically diagnosed) who are slated to undergo anti-PD L1/ neoadjuvant or palliative chemotherapy.
  • 2.Patients can provide sufficient tissues/blood for molecular analysis.
  • 3.Consent from patients for utilization of their tissues and blood for this study.

排除标准

  • 1.Pregnant women and patients under the age of 18
  • 2.Those who are unfit to provide biopsy samples as per protocol
  • 3.Those who refuse to consent to tissues being provided for research as per this protocol

研究者

相似试验